Optellum
Healthcare Software · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tmc Innovation Institute 2450, Holcombe,...Website
www.optellum.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
3
1
1
1
About Optellum
Optellum is a commercial-stage lung health company providing artificial intelligence decision-support software that assists physicians in early diagnosis and optimal treatment for their patients. The company was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, when chances of cure are the highest. Optellum's roadmap extends beyond lung cancer diagnosis and treatment to other deadly diseases of the lungs, including interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). Optellum has headquarters at the Oxford Centre for Innovation in Oxford, United Kingdom and a U.S. office at the Texas Medical Center in Houston, TX. Optellum has received grant funding from InnovateUK, the National Institute for Health Research (NIHR), the NHS AI Lab, The Accelerated Access Collaborative (AAC), MedCity, and EIT Health.Explore more
Optellum Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Optellum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Optellum had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Optellum has new funding data
Check out if Optellum is spiking on competitors!
Earning: See what the market has to say on Optellum recently announced quarterly report
Check if Optellum has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Optellum
Product Launch: Get notified when Optellum launches new products
Optellum, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Optellum as Masked Content
Find 2 more new buyers
Compare Similar Companies to Optellum
Compare insights from companies similar to Optellum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Optellum is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Optellum is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Optellum.
Optellum financials insights
Gather financial insights about Optellum, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$14M
Optellum Tech Stack
A closer look at the technologies used by Optellum
See more technologies
Most Recent Scoops
Project
, according to a front-line source in sales, is currently evaluating ZoomInfo solutions.
Sales
Project
, according to a front-line source in sales, is currently evaluating Growbots solutions.
Sales
Project
, according to a front-line source in sales, is currently evaluating Datanyze solutions.
Sales
Pain Point
Project
, according to a front-line source in sales, is planning to remediate challenges related to reaching targeted prospects.
Pain Point, Sales, Lead Management, Customer Marketing
Pain Point
Project
Pain Point, Sales
Optellum News & Media
Optellum AI Shown to be Highly Cost-Effective in First US Lifetime Payer Study of Lung Nodule Risk Stratification
HOUSTON, March 24, 2026 /PRNewswire/ -- First lifetime payer-perspective economic analysis of AI-assisted risk stratification for indeterminate pulmonary nodules (IPN). Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung...Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia
OXFORD, England, Feb. 26, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC) platform to...NHS launches a single end-to-end lung cancer diagnostic pathway initiative with Optellum
OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with robotic-assisted...Optellum and Volpara Health Announce Agreement for Lung & Breast Cancer Care
Collaboration brings together leading lung and breast imaging expertise to advance AI-driven cancer detection and early intervention. HOUSTON, March 4, 2025 /PRNewswire/ -- Optellum, the leader in AI-enabled lung cancer diagnosis, today announced it has entered a strategic agreement with...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Optellum
Sign Up For FreeTo access detailed company insights
Optellum is a commercial-stage lung health company providing artificial intelligence decision-support software that assists physicians in early diagnosis and optimal treatment for their patients. The company was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, when chances of cure are the highest.... Read More
